Retraction
Cannabinoid WIN 55,212-2 Inhibits Human Glioma Cell Growth by Triggering ROS-Mediated Signal Pathways
Paper Information
Record ID:
49154
Author(s):
Journal:
Publication Date:
April 23, 2021
Retraction Date:
July 12, 2023
(2.4 years years ago)
Subjects:
Institutions:
- Postdoctoral Workstation, Taian City Central Hospital, Tai’an, Shandong 271000, China
- School of Medicine, Shandong University, Jinan, Shandong 270021, China
- Basic Medical College, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai’an, Shandong 271000, China
- Key Lab of Cerebral Microcirculation in Universities of Shandong, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai’an, Shandong 271000, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
- Concerns/Issues About Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues with Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9803081Citations (13)
13
Total Citations4
Post-Retraction(30.8%)
9
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
0
After 2+ years
403
Days since retraction (latest)
Oxazine drug-seed induces paraptosis and apoptosis through reactive oxygen species/JNK pathway in human breast cancer cells
Na Young Kim, Dukanya Dukanya, Gautam Sethi et al. (18 authors)
Translational Oncology
Open Access
Published: Aug 2024
5 citations
5 citations
403 days after retraction
The antitumor action of endocannabinoids in the tumor microenvironment of glioblastoma
Yi Tang, Maoru Wang, Jiangping Yu et al. (6 authors)
Frontiers in Pharmacology
Open Access
Published: Apr 2024
1 citation
1 citation
287 days after retraction
Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions
Mireia Medrano, María Elena Muñoz Contreras, Teresa Caballero‐Velázquez et al. (9 authors)
British Journal of Cancer
Open Access
Published: Mar 2024
4 citations
4 citations
241 days after retraction
Targeting the Endocannabinoid System Present in the Glioblastoma Tumour Microenvironment as a Potential Anti-Cancer Strategy
Mendhi Henna Dasram, Pavesan Naidoo, Roderick B. Walker et al. (4 authors)
International Journal of Molecular Sciences
Open Access
Published: Jan 2024
6 citations
6 citations
195 days after retraction
N-linoleyltyrosine resisted the growth of non-small cell lung cancer cells via the regulation of CB1 and CB2 involvement of PI3K and ERK pathways
Yan Hu, Zhe Zhao, Yuanting Liu et al. (13 authors)
Frontiers in Pharmacology
Open Access
Published: Jun 2023
2 citations
2 citations
34 days before retraction
Natural and synthetic compounds for glioma treatment based on ROS-mediated strategy
Yufei Wang, Jinyue Hu
European Journal of Pharmacology
Published: Mar 2023
11 citations
11 citations
131 days before retraction
Retracted: Cannabinoid WIN 55,212-2 Inhibits Human Glioma Cell Growth by Triggering ROS-Mediated Signal Pathways
BioMed Research International
BioMed Research International
Open Access
Published: Jan 2023
192 days before retraction
Disorders of cancer metabolism: The therapeutic potential of cannabinoids
Dingya Sun, Xin Li, Shengdan Nie et al. (5 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Nov 2022
83 citations
83 citations
242 days before retraction
LCS-1 inhibition of superoxide dismutase 1 induces ROS-dependent death of glioma cells and degradates PARP and BRCA1
Min Ling, Qing Liu, Yufei Wang et al. (6 authors)
Frontiers in Oncology
Open Access
Published: Aug 2022
16 citations
16 citations
345 days before retraction
Targeting angiogenesis in gliomas: Potential role of phytochemicals
Mehdi Sanati, Amir R. Afshari, Javad Amini et al. (6 authors)
Journal of Functional Foods
Open Access
Published: Jul 2022
24 citations
24 citations
349 days before retraction
Endocannabinoid signaling in glioma
Carlos Costas‐Insua, Manuel Guzmán
Glia
Open Access
Published: Mar 2022
18 citations
18 citations
475 days before retraction
Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in Prostate and Other Cancer Cell Types Mediate Cell Death
Amal Shoeib, Lance Benson, Shengyu Mu et al. (5 authors)
International Journal of Molecular Sciences
Open Access
Published: Mar 2022
2 citations
2 citations
488 days before retraction
Inhalant Cannabidiol Inhibits Glioblastoma Progression Through Regulation of Tumor Microenvironment
Hesam Khodadadi, Évila Lopes Salles, Ahmet Alptekin et al. (13 authors)
Cannabis and Cannabinoid Research
Published: Dec 2021
22 citations
22 citations
572 days before retraction
Quick Stats
Total Citations:
13
Years Since Retraction:
2.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025